Author:
Xie Meilian,Wang Aiping,Zhang Zhiyun,Wang Kerong,Yu Yanping,Ma Xiaojing,Lin Zhaoxia,Yu Zhengli,Ke Jianxue
Abstract
Abstract
Background
“Perceived Symptom Manageability (PSM)” is essential in symptom management among people living with HIV. As a standardized assessment instrument was lacking, we developed a PSM scale for people living with human immunodeficiency virus (PSM-HIV).
Methods
Data analysis was performed using the sample from HIV-designated medical institutions (N = 540). Psychometric testing, namely reliability and validity, is assessed by unidimensionality, internal consistency, exploratory and confirmatory factor analysis, and structural equation modeling.
Results
The final version of the PSM- HIV scale contained 15 items. This scale was submitted to a principal components analysis with varimax rotation, and three factors were obtained, explained by a total variance of 63.10%. The three factors were named Cognitive-Behavioral, Affective Interaction, and Self-Attitude. The results show that the scale had high reliability, Cronbach’s α of the scale ranged from 0.71 to 0.92, and the Intraclass Correlation Coefficient was 0.88. The structural equation model supports a factor model with the acceptable fit (χ2/df (CMIN/DF) = 2.50, Root Mean square Residual (RMR) = 0.03, Goodness-of-Fit Index (GFI) = 0.93, Adjusted Goodness of Fit Index (AGFI) = 0.90, Normed Fit Index (NFI) = 0.93, Incremental Fit Index (IFI) = 0.96, Comparative Fit Index (CFI) = 0.96). The average variance extracted was 0.38 ∼ 0.59, and the composite reliability was 0.70 ∼ 0.91, indicating that the convergent validity of the scale is acceptable. Subjects with different stages of the disease reached significance(χ2 = 9.02; df = 2, P<0.05), meaning moderate Known-Groups Comparison Validation.
Conclusions
The PSM-HIV scale is a valid instrument that measures overall attitude and belief about controlling or coping with HIV-relevant symptoms.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. AIDS and Hepatitis C Professional Group SoID, Chinese Medical Association, Prevention CCfDCa: Chinese guidelines for diagnosis and treatment of HIV/AIDS. (2021). Chinese Journal of AIDS & STD 2021, 27(11):1182–1201.
2. Ambrosioni J, Levi L, Alagaratnam J, Van Bremen K, Mastrangelo A, Waalewijn H, Molina JM, Guaraldi G, Winston A, Boesecke C, et al. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Med. 2023;24(11):1126–36.
3. Zhu Z, Hu Y, Xing W, Guo M, Zhao R, Han S, Wu B. Identifying Symptom clusters among people living with HIV on antiretroviral therapy in China: A Network Analysis. J Pain Symptom Manage. 2019;57(3):617–26.
4. Zhu Z, Zhao R, Hu Y. Symptom clusters in people living with HIV: a systematic review. J Pain Symptom Manage. 2019;58(1):115–33.
5. Schnall R, Jia H, Reame N. Association between HIV Symptom Burden and Inflammatory cytokines: an analysis by sex and menopause stage. J Womens Health (Larchmt). 2020;29(1):119–27.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献